Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Riboxx GmbH (Riboxx Pharmaceuticals)

RIBOXX PHARMACEUTICALS is a biotech company developing proprietary Toll-like-receptor (TLR) ligands and RIG-I-like-Receptor (RLR) ligands for applications in cancer immunotherapy. RIBOXX IP portfolio includes 17 PCT patent families so far, with 8 PCT patents granted in EU and/or Japan. *

 

Period Start 2009-05-01 splitoff
  Predecessor Technical University Dresden (TU Dresden)
Products Industry siRNA technology
  Industry 2 Apoxxim® TLR3-ligand
Person Person Rohayem, Jacques (Riboxx 201602 CEO + CSO)
     
Region Region Radebeul
  Country Germany
  Street 191 Meißner Str.
Pharmapark Radebeul
  City 01445 Radebeul
  Tel +49-351-833601-0
    Address record changed: 2020-12-02
     
Basic data Employees B: 11 to 50 (2011-12-15)
     
    * Document for »About Section«: 
     
   
Record changed: 2023-12-30

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top